UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Ribbon Communications
RBBN
$386M
| $535K | ﹤0.01% |
65,122
-18,471
| -22% | -$153K |
|
|
AVTA
2302
DELISTED
Avantax, Inc. Common Stock
AVTA
| $530K | ﹤0.01% |
31,843
-10,864
| -25% | -$182K |
|
2303
NRC Health Common Stock
NRC
$412M
| $529K | ﹤0.01% |
11,296
| – | – |
|
|
FRG
2304
DELISTED
Franchise Group, Inc.
FRG
| $527K | ﹤0.01% |
14,600
+900
| +7% | +$31.9K |
|
|
KREF
2305
KKR Real Estate Finance Trust
KREF
$466M
| $525K | ﹤0.01% |
28,563
-7,542
| -21% | -$138K |
|
2306
Accel Entertainment
ACEL
$1B
| $525K | ﹤0.01% |
48,000
| – | – |
|
2307
Insteel Industries
IIIN
$592M
| $525K | ﹤0.01% |
17,011
+7,300
| +75% | +$218K |
|
2308
Arrow Financial
AROW
$662M
| $524K | ﹤0.01% |
17,206
+8,094
| +89% | +$238K |
|
2309
Clear Channel Outdoor Holdings
CCO
$1.22B
| $520K | ﹤0.01% |
288,741
+3,829
| +1% | +$7.25K |
|
2310
LoveSac
LOVE
$242M
| $516K | ﹤0.01% |
+9,119
| New | +$504K |
|
2311
Vir Biotechnology
VIR
$1.46B
| $516K | ﹤0.01% |
10,059
| – | – |
|
2312
Five Point Holdings
FPH
$387M
| $516K | ﹤0.01% |
68,215
+22,002
| +48% | +$147K |
|
2313
ImmunityBio
IBRX
$7.15B
| $515K | ﹤0.01% |
21,700
+9,500
| +78% | +$246K |
|
2314
National Presto Industries
NPK
$870M
| $514K | ﹤0.01% |
5,035
+2,114
| +72% | +$208K |
|
|
GBIO
2315
DELISTED
Generation Bio
GBIO
| $509K | ﹤0.01% |
+1,790
| New | +$573K |
|
2316
Camden National
CAC
$988M
| $509K | ﹤0.01% |
10,644
+4,778
| +81% | +$200K |
|
|
AGEN
2317
Agenus
AGEN
$276M
| $509K | ﹤0.01% |
9,528
+2,801
| +42% | +$202K |
|
|
UBA
2318
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $507K | ﹤0.01% |
30,446
+13,547
| +80% | +$213K |
|
2319
Hackett Group
HCKT
$281M
| $506K | ﹤0.01% |
30,847
| – | – |
|
|
FFG
2320
DELISTED
FBL Financial Group
FFG
| $506K | ﹤0.01% |
9,041
| – | – |
|
2321
Gossamer Bio
GOSS
$101M
| $506K | ﹤0.01% |
54,652
+12,200
| +29% | +$123K |
|
|
PAE
2322
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $502K | ﹤0.01% |
55,696
+12,796
| +30% | +$114K |
|
2323
Star Group
SGU
$413M
| $501K | ﹤0.01% |
47,330
| – | – |
|
|
SDC
2324
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $498K | ﹤0.01% |
48,328
+2,100
| +5% | +$24.9K |
|
|
CBAY
2325
DELISTED
Cymabay Therapeutics
CBAY
| $498K | ﹤0.01% |
109,621
+24,191
| +28% | +$130K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.